Related Experiment Videos
Radiotherapy-chemotherapy combinations in head and neck squamous cell carcinoma: overview of randomized trials
1Institut Gustave Roussy, Villejuif, France.
Anticancer Research
|July 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Discontinuation of the double-blind, placebo-controlled randomized, phase III GORTEC 2022-01 trial of radiotherapy-cetuximab and xevinapant in patients with locally advanced squamous cell carcinoma of the head and neck, unfit for cisplatin.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Clustering of dosimetric profiles reveals distinct local control probabilities after SABR in oligometastatic head and neck cancer: insights from the OMET phase II trial quality assurance Process.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
International guidelines for the delineation of the postoperative clinical target volumes (CTV) for parotid and submandibular gland cancers.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2025
[Proposal for the delineation of postoperative primary clinical target volumes in maxillary sinus and nasal cavity cancers].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2024
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
Utility of RNA Sequencing and Immunohistochemistry for NTRK Fusion in Thyroid Carcinoma.
Anticancer research·2026
Oxygen-Gradient-Responsive Photosensitizing Gadolinium Phthalocyaninate for Self-Adaptive Type II/I Photodynamic Therapy Toward Heterogeneous Tumor Suppression.
Small (Weinheim an der Bergstrasse, Germany)·2026
An Immunogenic Cell Death-Enhanced Self-Assembled Nanoparticle-Composite Hydrogel for Postoperative Local Immunotherapy of Melanoma.
Omics : a journal of integrative biology·2026